Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00453271
Status:
COMPLETED
Last Update Posted:
2013-05-23
First Post:
2007-03-26
Brief Title:
Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail
Sponsor:
NanoBio Corporation
Organization:
NanoBio Corporation
Study Overview
Official Title:
A Randomized Double-Blind Parallel-GroupMulticenter Dose-Response Vehicle-Controlled Study of the Safety and Efficacy of NB-002 in the Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail
Status:
COMPLETED
Status Verified Date:
2013-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to determine whether NB002 025 and 05 are safe and effective in the treatment of distal subungual onychomycosis of the toenail
Detailed Description:
The purpose of the study is to determine whether NB002 025 and 05 are safe and effective in the treatment of distal subungual onychomycosis of the toenail
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None